Company: HRTX
Filing Date: 2025-02-27
Form Type: 10-K
Source: 0000950170-25-028374
Chunk: 192

Company: HERON THERAPEUTICS, INC. /DE/
Filing Date: 2025-02-27
Form: 10-K
Item: Item 8
Chunk 192
---
 36,529

        Provision

        (174
        )

        30,045

        206,662

        236,533

        Payments/credits

        (811
        )

        (28,581
        )

        (206,251
        )

        (235,643
        )

        Balance at December 31, 2024
         
        $
        3,791

        $
        5,883

        $
        27,745

        $
        37,419

6.Commitments and ContingenciesLeasesAs of December 31, 2024, we had an operating lease for 52,148 square feet of laboratory and office space in San Diego, California, with a lease term that expires on December 31, 2025. In October 2021, we entered into a sublease agreement to sublet 23,873 square feet of laboratory and office space. The space was delivered to the subtenant in March 2022. As a result of the sublease agreement, our one five-year option to renew the lease on expiration applies only with respect to our remaining 28,275 square feet of laboratory and office space.In September 2023, we also entered into a sublease agreement to sublet 5,840 square feet of office space in Cary, North Carolina, with a lease term that expires on April 30, 2025.In September 2024, we entered into a short-term sublease agreement to sublet 9,882 square feet of office space in Cary, North Carolina, with a lease term that expires on August 31, 2025.

87

Annual future minimum lease payments as of December 31, 2024 are as follows (in thousands): 

        Year ended December 31:

        2025
         
        $
        3,138

        Total future minimum lease payments

        3,138

        Less: discount

        (101
        )

        Total lease liabilities
         
        $
        3,037

      Rent expense under all operating leases totaled $3.0 million, $2.9 million and $2.8 million for the years ended December 31, 2024 , 2023 and 2022, respectively. During the years ended December 31, 2024, 2023 and 2022, we paid $3.2 million, $3.0 million and $2